These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 20693422)
1. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. Serriari NE; Gondois-Rey F; Guillaume Y; Remmerswaal EB; Pastor S; Messal N; Truneh A; Hirsch I; van Lier RA; Olive D J Immunol; 2010 Sep; 185(6):3140-8. PubMed ID: 20693422 [TBL] [Abstract][Full Text] [Related]
2. Cutting edge: programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection. Zhang JY; Zhang Z; Jin B; Zhang SY; Zhou CB; Fu JL; Wang FS J Immunol; 2008 Sep; 181(6):3741-4. PubMed ID: 18768824 [TBL] [Abstract][Full Text] [Related]
3. Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults. Duraiswamy J; Ibegbu CC; Masopust D; Miller JD; Araki K; Doho GH; Tata P; Gupta S; Zilliox MJ; Nakaya HI; Pulendran B; Haining WN; Freeman GJ; Ahmed R J Immunol; 2011 Apr; 186(7):4200-12. PubMed ID: 21383243 [TBL] [Abstract][Full Text] [Related]
4. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. Velu V; Kannanganat S; Ibegbu C; Chennareddi L; Villinger F; Freeman GJ; Ahmed R; Amara RR J Virol; 2007 Jun; 81(11):5819-28. PubMed ID: 17376899 [TBL] [Abstract][Full Text] [Related]
5. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation. Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623 [TBL] [Abstract][Full Text] [Related]
6. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses. Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490 [TBL] [Abstract][Full Text] [Related]
7. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time. Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443 [TBL] [Abstract][Full Text] [Related]
8. Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells. Dirks J; Egli A; Sester U; Sester M; Hirsch HH Transpl Infect Dis; 2013 Feb; 15(1):79-89. PubMed ID: 23176118 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells. Vieira Braga FA; Hertoghs KM; van Lier RA; van Gisbergen KP Eur J Immunol; 2015 Sep; 45(9):2433-45. PubMed ID: 26228786 [TBL] [Abstract][Full Text] [Related]
10. Hepatic expansion of virus-specific CD8 Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606 [TBL] [Abstract][Full Text] [Related]
11. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065 [TBL] [Abstract][Full Text] [Related]
12. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells. Wang XF; Chen YJ; Wang Q; Ge Y; Dai Q; Yang KF; Fang-Xie ; Zhou YH; Hu YM; Mao YX; Zhang XG Tissue Antigens; 2007 Feb; 69(2):145-53. PubMed ID: 17257317 [TBL] [Abstract][Full Text] [Related]
13. B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation. Liu Y; Nie W; Jin Y; Zhuo A; Zang Y; Xiu Q Iran J Immunol; 2016 Jun; 13(2):89-99. PubMed ID: 27350630 [TBL] [Abstract][Full Text] [Related]
14. Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study. Di Benedetto S; Derhovanessian E; Steinhagen-Thiessen E; Goldeck D; Müller L; Pawelec G Biogerontology; 2015 Oct; 16(5):631-43. PubMed ID: 25732234 [TBL] [Abstract][Full Text] [Related]
15. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection. Nan XP; Zhang Y; Yu HT; Li Y; Sun RL; Wang JP; Bai XF Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403 [TBL] [Abstract][Full Text] [Related]
16. HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals. Ventura C; Bisceglia H; Girerd-Chambaz Y; Burdin N; Chaux P J Clin Immunol; 2012 Dec; 32(6):1305-16. PubMed ID: 22797815 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698 [TBL] [Abstract][Full Text] [Related]
18. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Otsuki N; Kamimura Y; Hashiguchi M; Azuma M Biochem Biophys Res Commun; 2006 Jun; 344(4):1121-7. PubMed ID: 16643847 [TBL] [Abstract][Full Text] [Related]
19. B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses. Kashiwakuma D; Suto A; Hiramatsu Y; Ikeda K; Takatori H; Suzuki K; Kagami S; Hirose K; Watanabe N; Iwamoto I; Nakajima H J Immunol; 2010 Sep; 185(5):2730-6. PubMed ID: 20660710 [TBL] [Abstract][Full Text] [Related]
20. BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination. Derré L; Rivals JP; Jandus C; Pastor S; Rimoldi D; Romero P; Michielin O; Olive D; Speiser DE J Clin Invest; 2010 Jan; 120(1):157-67. PubMed ID: 20038811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]